Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · IEX Real-Time Price · USD
1.630
-0.020 (-1.21%)
At close: Jul 2, 2024, 4:00 PM
1.639
+0.009 (0.55%)
After-hours: Jul 2, 2024, 5:38 PM EDT
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $78.66 million as of July 2, 2024. Its market cap has decreased by -68.57% in one year.
Market Cap
78.66M
Enterprise Value
-68.94M
1-Year Change
-68.57%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $78.66M, a decrease of -85.79%. That is a compound annual growth rate of -44.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 79.60M | -16.30% |
| Dec 29, 2023 | 95.10M | -1.35% |
| Dec 30, 2022 | 96.40M | -78.59% |
| Dec 31, 2021 | 450.30M | -18.63% |
| Mar 26, 2021 | 553.41M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EUDA Health Holdings | 81.96M |
| Aclaris Therapeutics | 81.95M |
| Sensus Healthcare | 81.72M |
| Assembly Biosciences | 81.64M |
| PMV Pharmaceuticals | 81.28M |
| Connect Biopharma Holdings | 79.35M |
| DBV Technologies | 78.77M |
| Allakos | 77.90M |